Showing results (321-330 of 353) with videos related to

Sort By:
Pageof 36
MMWR. Morbidity and Mortality Weekly Report|March 15, 2023
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
BMJ (Clinical Research Ed.)|October 3, 2022
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control studyJill M Ferdinands, Suchitra Rao, Brian E Dixon, et al.
Lancet Regional Health. Americas|October 3, 2025
Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023-March 2024: a test-negative design analysisAmanda B Payne, Steph Battan-Wraith, Elizabeth A K Rowley, et al.
JAMA Network Open|June 25, 2025
Estimated 2023-2024 COVID-19 Vaccine Effectiveness in AdultsRuth Link-Gelles, Elizabeth A K Rowley, Stephanie A Irving, et al.
MMWR. Morbidity and Mortality Weekly Report|December 29, 2022
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
Lancet (London, England)|October 19, 2024
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysisAmanda B Payne, Janet A Watts, Patrick K Mitchell, et al.
JAMA Internal Medicine|June 15, 2026
Estimated Effectiveness of 2024-2025 COVID-19 Vaccines in AdultsRyan E Wiegand, Amanda B Payne, Josephine Mak, et al.
NEJM Evidence|May 19, 2023
Covid-19 Rates by Time since Vaccination during Delta Variant PredominanceGabriela Paz-Bailey, Maya Sternberg, Kiersten Kugeler, et al.
MMWR. Morbidity and Mortality Weekly Report|October 20, 2022
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022Amadea Britton, Peter J Embi, Matthew E Levy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2023
Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine EffectivenessAlexandra F Dalton, Zachary A Weber, Katie S Allen, et al.
Pageof 36